Aflibercept (Eylea®)

Assessment Status Rapid Review Complete
HTA ID -
Drug Aflibercept
Brand Eylea®
Indication For the treatment of neovascular (wet) age-related macular degeneration (AMD).
Assessment Process
Rapid review commissioned 10/12/2012
Rapid review completed 21/12/2012
Rapid review outcome Full Pharmacoeconomic Assessment Recommended